These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30138759)

  • 21. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.
    Price GA; Holmes RK
    PLoS One; 2012; 7(8):e42434. PubMed ID: 22879984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obtaining and Characteristic of Antibodies to Vibrio cholerae Protective Antigens Conjugated with Gold Nanoparticles.
    Dykman LA; Volokh OA; Gromova OV; Durakova OS; Vorobeva SA; Kireev MN; Livanova LF; Nikiforov AK; Shchyogolev SY; Kutyrev VV
    Dokl Biochem Biophys; 2020 Jan; 490(1):19-21. PubMed ID: 32342306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
    Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
    Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine.
    Murugaiah C; Nik Mohd Noor NZ; Mustafa S; Manickam R; Pattabhiraman L
    PLoS One; 2014; 9(2):e81817. PubMed ID: 24505241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.
    Migasena S; Desakorn V; Suntharasamai P; Pitisuttitham P; Prayurahong B; Supanaranond W; Black RE
    Infect Immun; 1989 Jan; 57(1):117-20. PubMed ID: 2909484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with a bicistronic DNA vaccine modulates systemic IFN-γ and IL-10 expression against
    Ahmad Zamri N; Rusli MEF; Mohamad Yusof L; Rosli R
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35635780
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139.
    Kumar S; Ray P; Singh H; Ganguly NK
    J Med Microbiol; 2001 Jun; 50(6):489-498. PubMed ID: 11393286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice.
    Barati B; Ebrahimi F; Nazarian S
    Iran J Immunol; 2018 Mar; 15(1):47-58. PubMed ID: 29549232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenium Nanoparticles Induce Potent Protective Immune Responses against
    Raahati Z; Bakhshi B; Najar-Peerayeh S
    J Immunol Res; 2020; 2020():8874288. PubMed ID: 33490291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and characterization of a Vibrio cholerae serogroup O139 vaccine candidate by genetic engineering.
    Cheng C; Zhou Y; Kan B; Wang Q; Rui Y
    Mol Med Rep; 2014 Jun; 9(6):2239-44. PubMed ID: 24676972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].
    Carrada-Bravo T
    Rev Alerg Mex; 1994; 41(3):69-76. PubMed ID: 9377108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression and immunity of Legionella pneumophila mip gene and immunoadjuvant ctxB gene.
    Wang T; Chen JP; Li H; Zhi KQ; Zhang L; Yang CL; Tao DC
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):199-204. PubMed ID: 15756423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
    Pierce NF; Cray WC; Sacci JB
    Infect Immun; 1982 Aug; 37(2):687-94. PubMed ID: 6889574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A one dose experimental cholera vaccine.
    Muse M; Grandjean C; Wade TK; Wade WF
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
    Wang Z; Lazinski DW; Camilli A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.